Affordable Access

Publisher Website

Association between Plasma Antibody Response and Protection in Rainbow Trout Oncorhynchus mykiss Immersion Vaccinated against Yersinia ruckeri

Authors
Journal
PLoS ONE
1932-6203
Publisher
Public Library of Science
Publication Date
Volume
6
Issue
6
Identifiers
DOI: 10.1371/journal.pone.0018832
Keywords
  • Research Article
  • Biology
  • Immunology
  • Immunity
  • Adaptive Immunity
  • Immune Activation
  • Immune Defense
  • Immunity To Infections
  • Immunizations
  • Inflammation
  • Innate Immunity
  • Immunoglobulins
  • Immunologic Techniques
  • Model Organisms
  • Animal Models
  • Medicine
  • Clinical Immunology
  • Immune Response
  • Drugs And Devices
  • Drug Research And Development
  • Drug Discovery
  • Infectious Diseases
  • Oral Medicine
  • Veterinary Science
  • Animal Management
  • Animal Welfare
  • Animal Types
  • Aquatic Animals
  • Veterinary Diseases
  • Veterinary Bacteriology
  • Veterinary Medicine
  • Veterinary Immunology
  • Veterinary Microbiology
  • Veterinary Pathology
  • Veterinary Pharmacology
Disciplines
  • Biology
  • Medicine

Abstract

A key hallmark of the vertebrate adaptive immune system is the generation of antigen-specific antibodies from B cells. Fish are the most primitive gnathostomes (jawed vertebrates) possessing an adaptive immune system. Vaccination of rainbow trout against enteric redmouth disease (ERM) by immersion in Yersinia ruckeri bacterin confers a high degree of protection to the fish. The immune mechanisms responsible for protection may comprise both cellular and humoral elements but the role of specific immunoglobulins in this system has been questioned and not previously described. The present study demonstrates significant increase in plasma antibody titers following immersion vaccination and significantly reduced mortality during Y. ruckeri challenge. Rainbow trout were immersion-vaccinated, using either a commercial ERM vaccine (AquaVac™ ERM vet) or an experimental Y. ruckeri bacterin. Half of the trout vaccinated with AquaVac™ ERM vet received an oral booster (AquaVac™ ERM Oral vet). Sub-groups of the fish from each group were subsequently exposed to 1x109 CFU Y. ruckeri/ml either eight or twenty-six weeks post vaccination (wpv). All vaccinated groups showed 0% mortality when challenged, which was highly significant compared to the non-vaccinated controls (40 and 28% mortality eight and twenty-six weeks post vaccination (wpv), respectively) (P<0.0001). Plasma samples from all groups of vaccinated fish were taken 0, 4, 8, 12, 16 and 26 wpv. and Y. ruckeri specific IgM antibody levels were measured with ELISA. A significant increase in titers was recorded in vaccinated fish, which also showed a reduced bacteremia during challenge. In vitro plasma studies showed a significantly increased bactericidal effect of fresh plasma from vaccinated fish indicating that plasma proteins may play a role in protection of vaccinated rainbow trout.

There are no comments yet on this publication. Be the first to share your thoughts.